HSBC Holdings
BIO icon

HSBC Holdings’s Bio-Rad Laboratories Class A BIO Stock Holding History

HSBC Holdings’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.31M Buy
+15,585
New +$4.49M ﹤0.01% 1213
2025
Q2 		– Sell
-3,977
Closed -$964K – 3040
2025
Q1 		$964K Sell
3,977
-257
-6% -$77.3K ﹤0.01% 1768
2024
Q4 		$1.39M Buy
4,234
+258
+6% +$87.6K ﹤0.01% 1648
2024
Q3 		$1.33M Sell
3,976
-29,874
-88% -$9.49M ﹤0.01% 1578
2024
Q2 		$9.25M Buy
33,850
+6,450
+24% +$1.88M 0.01% 890
2024
Q1 		$9.47M Sell
27,400
-1,667
-6% -$548K 0.01% 898
2023
Q4 		$9.4M Buy
29,067
+7,426
+34% +$2.33M 0.01% 914
2023
Q3 		$7.76M Buy
21,641
+5,587
+35% +$2.16M 0.01% 927
2023
Q2 		$6.09M Sell
16,054
-3,094
-16% -$1.26M 0.01% 984
2023
Q1 		$9.16M Sell
19,148
-64,834
-77% -$30.3M 0.01% 888
2022
Q4 		$35.3M Sell
83,982
-11,952
-12% -$4.82M 0.04% 460
2022
Q3 		$40.1M Buy
95,934
+2,620
+3% +$1.31M 0.07% 313
2022
Q2 		$46.2M Sell
93,314
-1,380
-1% -$719K 0.06% 306
2022
Q1 		$53.7M Sell
94,694
-7,575
-7% -$4.57M 0.07% 291
2021
Q4 		$77.2M Sell
102,269
-7,976
-7% -$5.97M 0.07% 262
2021
Q3 		$82.3M Sell
110,245
-14,164
-11% -$10.6M 0.08% 195
2021
Q2 		$80.3M Buy
124,409
+11,177
+10% +$6.8M 0.09% 221
2021
Q1 		$64.6M Buy
113,232
+32,724
+41% +$19.4M 0.08% 261
2020
Q4 		$46.9M Buy
80,508
+6,197
+8% +$3.53M 0.06% 302
2020
Q3 		$38.4M Buy
74,311
+20,648
+38% +$10.5M 0.06% 287
2020
Q2 		$24.2M Buy
53,663
+36,394
+211% +$16.1M 0.05% 375
2020
Q1 		$6.05M Buy
17,269
+12,712
+279% +$4.67M 0.01% 766
2019
Q4 		$1.7M Sell
4,557
-2,067
-31% -$729K ﹤0.01% 1562
2019
Q3 		$2.21M Buy
6,624
+4,311
+186% +$1.41M ﹤0.01% 1553
2019
Q2 		$723K Sell
2,313
-17,159
-88% -$5.14M ﹤0.01% 1914
2019
Q1 		$5.95M Sell
19,472
-3,674
-16% -$991K 0.01% 1038
2018
Q4 		$5.38M Buy
23,146
+5,608
+32% +$1.5M 0.01% 1075
2018
Q3 		$5.49M Buy
17,538
+15,606
+808% +$4.84M 0.01% 1091
2018
Q2 		$557K Buy
1,932
+212
+12% +$58.5K ﹤0.01% 2026
2018
Q1 		$430K Buy
1,720
+11
+0.6% +$2.8K ﹤0.01% 2018
2017
Q4 		$408K Buy
1,709
+273
+19% +$66.2K ﹤0.01% 1580
2017
Q3 		$319K Buy
1,436
+249
+21% +$56K ﹤0.01% 1914
2017
Q2 		$269K Sell
1,187
-359
-23% -$78.2K ﹤0.01% 1928
2017
Q1 		$308K Sell
1,546
-60
-4% -$11.6K ﹤0.01% 1794
2016
Q4 		$293K Sell
1,606
-225,159
-99% -$38.4M ﹤0.01% 2251
2016
Q3 		$37.1M Sell
226,765
-50,287
-18% -$7.63M 0.09% 243
2016
Q2 		$39.6M Sell
277,052
-49,972
-15% -$7.13M 0.11% 211
2016
Q1 		$44.7M Buy
327,024
+99,938
+44% +$13.1M 0.13% 186
2015
Q4 		$31.5M Buy
227,086
+75,057
+49% +$10.4M 0.08% 294
2015
Q3 		$20.4M Buy
152,029
+150,133
+7,918% +$21.6M 0.05% 399
2015
Q2 		$285K Sell
1,896
-178
-9% -$25.5K ﹤0.01% 1640
2015
Q1 		$281K Buy
+2,074
New +$257K ﹤0.01% 1769
2014
Q3 		– Sell
-4,233
Closed -$507K – 1738
2014
Q2 		$507K Buy
+4,233
New +$517K ﹤0.01% 1457

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HSBC Holdings's BIO Position: Q1 2026 in Review

HSBC Holdings opened a new position in Bio-Rad Laboratories Class A (BIO) in Q1 2026: 15,585 shares worth $4.31M. The stake represents ﹤0.01% of the portfolio and ranks #1213 among its holdings. This is a return to the name: HSBC Holdings previously reported a position in BIO as recently as Q1 2025.

HSBC Holdings first reported a position in BIO in Q2 2014 and has held it in 43 quarters since. The position peaked at $82.3M in Q3 2021. 391 funds tracked by Wall St. Rank hold BIO as of Q1 2026.

  • HSBC Holdings held 15,585 shares of Bio-Rad Laboratories Class A worth $4.31M as of Q1 2026.
  • Bio-Rad Laboratories Class A was a new HSBC Holdings position in Q1 2026.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #1213 holding.
  • HSBC Holdings first reported a position in Bio-Rad Laboratories Class A in Q2 2014 and has held it in 43 quarters since.
  • HSBC Holdings's Bio-Rad Laboratories Class A position peaked at $82.3M in Q3 2021.
  • 391 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.